Enbrel (etanercept) is a prescription drug used to treat certain inflammatory conditions. This drug can interact with certain medications and vaccines. For example, Enbrel can interact with ...

Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations ...

Chicago-based biotech Cour Pharmaceuticals announced the hiring of former Acelyrin executive Paul M. Peloso, MD as chief ...

The global biopharmaceuticals market is poised for significant growth, with its value expected to reach USD 566 billion by ...

Amgen Inc (NASDAQ:AMGN) has recently announced a dividend of $2.25 per share, set to be payable on June 7, 2024, with the ...

Both stocks have been in the limelight lately, given their focus on the lucrative weight-loss treatment market.

Dr. Peloso to lead COUR’s clinical development programs as the company advances towards late-stage developmentCHICAGO, May 21, 2024 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage ...

The Specialty Pharmaceutical Market is experiencing significant growth, driven by several key factors. The market is projected to grow from USD 68.3 billion in 2023 to USD 1532.8 billion by 2033, ...

James K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against ...

This analysis did not drill down to the level of individual patents to assess their legitimacy, Kesselheim stressed. However, ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Otezla had sales of $394 million, up 1% compared to Q1 2023, and Enbrel had sales of $567 million, representing a 2% decline. Horizon Therapeutics, which Amgen bought last year for around $28 billion, ...